RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Fintel reports that on January 10, 2025, RBC Capital upgraded their outlook for KB Home (NYSE:KBH) from Underperform to ...

In the last two years, it’s happened for the fifth time. The S&P 500 was up 26% in 2023 and 25% in 2024, for the best ...

RBC Capital initiated coverage of Amentum (AMTM) with a Sector Perform rating and $24 price target Amentum is a leading government services ...

RBC Capital analyst Mike Dahl raised the firm’s price target on Vulcan Materials (VMC) to $269 from $259 and keeps a Sector Perform rating on ...

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...